Blueprint Neurotherapeutics Network for Biologics Q&A Webinar

Thursday, May 05, 2022
Image
NIH Default Logo

The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics), which provides non-dilutive support for biologics neurotherapeutics discovery and development, from lead optimization through phase I clinical testing, held a Q&A Webinar for potential applicants on Thursday, May 5th, 2022. Acting Program Director Dr. Mario Skiadopoulos provided an overview of the program and answered questions about the application process.

PAR-21-163 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

PAR-20-122  Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Next Receipt date for both BPN-Biologics Funding Opportunities is August 9th, 2022.

Webinar slides(pdf, 2060 KB)

Was this page helpful?
Form Approved OMB# 0925-0648 Exp. Date 06/2024